Apr 30, 2014
Novartis’ Zykadia Approved for Late-Stage Lung Cancer
Sixth Breakthrough Drug to Gain Wide Approval
Colorado U.S. Senator Michael Bennet welcomed the U.S. Food and Drug Administration’s (FDA) approval of another breakthrough drug – this time for a lung cancer drug manufactured by Novartis. The drug, known as Z...